OTCMKTS:SCIE

SpectraScience Stock Forecast, Price & News

$0.0002
0.00 (0.00 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00▼
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00▼
$0.01
Volume14.89 million shs
Average Volume213.05 million shs
Market Capitalization$176,734.00
P/E RatioN/A
Dividend YieldN/A
Beta0.96
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SCIE
Previous Symbol
CUSIP84760E301
CIK727672
Webwww.spectrascience.com
Phone858-847-0200
Employees5
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares883,670,000
Market Cap$176,734.00
Next Earnings DateN/A
OptionableNot Optionable

Headlines

SpectraScience, Inc. (OTCMKTS:SCIE) Short Interest Down 99.2% in March
April 13, 2021 |  americanbankingnews.com
STREETWISE: Beware the rise of penny stocks
March 28, 2021 |  msn.com
SpectraScience, Inc. (OTCMKTS:SCIE) Short Interest Up 1,359.8% in March
March 27, 2021 |  americanbankingnews.com
Penny Stocks Thrive as Small Investors Flood the Market, Raising Fraud Concerns
March 19, 2021 |  finance.yahoo.com
Penny Stocks Are Booming, Which Is Good News for Swindlers
March 18, 2021 |  nytimes.com
U.S. markets regulator suspends trading in defunct 'meme stock'
February 12, 2021 |  reuters.com
SEC Suspends Trading in Inactive Issuer Touted on Social Media
February 12, 2021 |  markets.businessinsider.com
Cannabis stocks chill after red-hot rally
February 11, 2021 |  reuters.com
U.S. markets regulator suspends trading in defunct ‘meme stock’
February 11, 2021 |  theglobeandmail.com
U.S. regulator suspends trading in inactive Minnesota company
February 11, 2021 |  reuters.com
US suspends trading in penny stock as regulator sharpens gaze
February 11, 2021 |  ft.com
SpectraScience Inc.
December 25, 2020 |  barrons.com
OtcbbJournal.com, Looks at Micro-Caps That Could Be Big Winners This Fall
May 21, 2020 |  www.bloomberg.com
See More Headlines

MarketRank™

Overall MarketRank™

0.48 out of 5 stars

Medical Sector

1639th out of 2,021 stocks

Electromedical Equipment Industry

46th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.0002
0.00 (0.00 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SCIE News and Ratings via Email

Sign-up to receive the latest news and ratings for SCIE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SpectraScience (OTCMKTS:SCIE) Frequently Asked Questions

What stocks does MarketBeat like better than SpectraScience?

Wall Street analysts have given SpectraScience a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SpectraScience wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting SpectraScience?

SpectraScience saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 52,500 shares, a drop of 99.2% from the March 15th total of 6,404,100 shares. Based on an average trading volume of 65,178,800 shares, the days-to-cover ratio is presently 0.0 days.
View SpectraScience's Short Interest.

How has SpectraScience's stock price been impacted by COVID-19 (Coronavirus)?

SpectraScience's stock was trading at $0.0001 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SCIE shares have increased by 100.0% and is now trading at $0.0002.
View which stocks have been most impacted by COVID-19.

Who are SpectraScience's key executives?

SpectraScience's management team includes the following people:
  • Mr. Michael P. Oliver, CEO, Pres, COO & Director (Age 73, Pay $325k)
  • Mr. Lowell W. Giffhorn, CFO & Sec. (Age 74, Pay $90k)

Who are some of SpectraScience's key competitors?

Some companies that are related to SpectraScience include Guided Therapeutics (GTHP), IMRIS (IMRSQ), Echo Therapeutics (ECTE), Urologix (ULGX), Aksys (AKSY), Escalon Medical (ESMC), Heart Tronics (HRTT), Ivivi Technologies (IVVI), NewCardio (NWCI), Pace Medical (PMDL), Photoelectron (PECN), Positron (POSC), Trimedyne (TMED) and Xcorporeal (XCRP).
View all of SCIE's competitors.

What other stocks do shareholders of SpectraScience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SpectraScience investors own include Spectrum Brands (SPB), Bloom Energy (BE), Dermira (DERM), CytoDyn (CYDY), Trimble (TRMB), Delek US (DK), Concho Resources (CXO), Cardtronics (CATM), (APA) and The Andersons (ANDE).

What is SpectraScience's stock symbol?

SpectraScience trades on the OTCMKTS under the ticker symbol "SCIE."

How do I buy shares of SpectraScience?

Shares of SCIE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SpectraScience's stock price today?

One share of SCIE stock can currently be purchased for approximately $0.00.

How much money does SpectraScience make?

SpectraScience has a market capitalization of $176,734.00.

How many employees does SpectraScience have?

SpectraScience employs 5 workers across the globe.

What is SpectraScience's official website?

The official website for SpectraScience is www.spectrascience.com.

Where are SpectraScience's headquarters?

SpectraScience is headquartered at 11568 SORRENTO VALLEY ROAD SUITE 11, SAN DIEGO CA, 92121.

How can I contact SpectraScience?

SpectraScience's mailing address is 11568 SORRENTO VALLEY ROAD SUITE 11, SAN DIEGO CA, 92121. The company can be reached via phone at 858-847-0200.


This page was last updated on 4/16/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.